SUBSCRIBE
SUBSCRIBE
News   Business

Keryx Biopharmaceuticals Takes Bigger Loss ($4.7 Million) As Research Spending Grows

March 25, 2010 | 
1 min read

NEW YORK (AP) -- Keryx Biopharmaceuticals Inc. reported a larger fourth-quarter loss Wednesday as its spending on research and development tripled from a year ago.

Earnings
MORE ON THIS TOPIC
Profit and Money Concept, Financial and Business Graph
Drug pricing
Drug Price Watchdog Calls Out Five Pharmas for Unjustified Price Hikes
December 13, 2024
 · 
3 min read
 · 
Annalee Armstrong
cutting off a row of people into pieces
Layoffs
Editas Axes 60% of Staff, Sickle Cell Therapy After Failing to Find Partner
December 13, 2024
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Bavarian, BenevolentAI, Chroma Medicine and Nvelop Therapeutics Cut Staff
December 12, 2024
 · 
205 min read
 · 
BioSpace Editorial Staff
Podcast
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
December 11, 2024
 · 
1 min read
 · 
Heather McKenzie